Filing Flows › Delcath Systems (DCTH) › Recalls, complaints & regulation
Delcath Systems (DCTH): clinical trials
Delcath Systems (DCTH) beyond its filings: 3 active clinical trials.
Delcath Systems' latest quarter
Delcath Systems, Q2 2026: revenue $29.1M (+21% year over year), operating margin 8.2%, net earnings $2.7M, operating cash flow $5.7M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Delcath Systems have?
3 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.